Daewon to release new anti-osteoarthritis drug

Daewon Pharm said on April 23 that its home-grown Peluvi tablets (felubiprofen), new NSAID (nonsteroidal anti-inflammatory drug) for treatment of osteoarthritis, was approved by the Korea Food and Drug Administration. The medication is expected to be available in the latter of this year.

Preclinical studies showed that felubiprofen was more potent than conventional drugs in terms of anti-inf...